SAMDaily.us | SNOTE | Q | Study The Acute Effects Of Metreleptin In Humans With Lipodystrophy

SAMDAILY.US - ISSUE OF JULY 02, 2020 SAM #6790
SPECIAL NOTICE

Q -- Study The Acute Effects Of Metreleptin In Humans With Lipodystrophy

Notice Date: 6/30/2020 7:41:32 AM
Notice Type: Special Notice
NAICS: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Contracting Office: NATIONAL INSTITUTES OF HEALTH NICHD BETHESDA MD 20817 USA
ZIP Code: 20817
Solicitation Number: NIH-NICHD-20-108
Response Due: 7/10/2020 7:00:00 AM
Archive Date: 07/11/2020
Point of Contact: April N Martin, Phone: 3014356962
E-Mail Address: april.martin@nih.gov
(april.martin@nih.gov)
Description: The National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Office of Acquisitions (OA) on behalf of the on behalf of the National Institute of Digestive, Diabetes & Kidney Diseases intends to award a purchase order without providing for full and open competition (Including brand-name) to METABOLON, INC to conduct a study to study the acute effects of metreleptin in humans with lipodystrophy.
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/afbca5d9bbf64a97b7b028f2c9a57fb8/view)
Place of Performance: Address: Bethesda, MD 20892-0001, USA; Zip Code: 20892-0001; Country: USA
Record: SN05707545-F 20200702/200630230141 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |